Kwan Woo Lee
Overview
Explore the profile of Kwan Woo Lee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
84
Citations
1082
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Heo Y, Park J, Lee N, Choi S, Jeon J, Han S, et al.
FASEB J
. 2024 Jul;
38(15):e23859.
PMID: 39082187
Metabolic dysfunction-associated steatotic liver disease (MASLD) is strongly associated with insulin resistance development. Hepatic lipid accumulation and inflammation are considered the main drivers of hepatic insulin resistance in MASLD. Cysteine-rich...
2.
Cho Y, Park H, Seo D, Ahn S, Hong S, Suh Y, et al.
Yonsei Med J
. 2024 Jul;
65(8):427-433.
PMID: 39048318
Purpose: Few studies have investigated the association between smoking and microvascular complications in the Asian population with type 2 diabetes mellitus (T2DM). We aimed to investigate the relationship between smoking...
3.
Lee J, Kang Y, Jeon J, Kim H, Kim D, Lee K, et al.
J Pharmacol Sci
. 2024 Apr;
155(2):35-43.
PMID: 38677784
Imeglimin is a novel oral antidiabetic drug for treating type 2 diabetes. However, the effect of imeglimin on NLRP3 inflammasome activation has not been investigated yet. Here, we aimed to...
4.
Park H, Cho Y, Seo D, Ahn S, Hong S, Suh Y, et al.
Sci Rep
. 2024 Mar;
14(1):5568.
PMID: 38448443
The effect of diabetes distress on glycemic control and its association with diabetes complications is still poorly understood. We aimed to study the clinical features of patients with high diabetes...
5.
Heo Y, Lee N, Choi S, Jeon J, Han S, Kim D, et al.
Mediators Inflamm
. 2023 Oct;
2023:2364121.
PMID: 37868614
Background: Inflammation is a major cause of hepatic tissue damage and accelerates the progression of nonalcoholic fatty liver disease (NAFLD). Amphiregulin (AREG), an epidermal growth factor receptor ligand, is associated...
6.
Park H, Kim K, Min K, Sohn T, Jeong I, Ahn C, et al.
Diabetes Obes Metab
. 2023 Jun;
25(9):2743-2755.
PMID: 37337747
Aims: To evaluate the effect of dapagliflozin on body composition such as total body fat (BF) mass, abdominal visceral adipose tissue (VAT), and subcutaneous adipose tissue (SAT) areas compared with...
7.
Lee C, Lee S, Park S, Choi S, Song M, Lee H, et al.
Int J Mol Sci
. 2022 Sep;
23(17).
PMID: 36077368
The accumulation of hepatic lipid droplets (LDs) is a hallmark of non-alcoholic fatty liver disease (NAFLD). Appropriate degradation of hepatic LDs and oxidation of complete free fatty acids (FFAs) are...
8.
Choi S, Hwang Y, Lee S, Jung H, Shin T, Son Y, et al.
J Hepatol
. 2022 Apr;
77(3):735-747.
PMID: 35421426
Background & Aims: Mitochondrial dysfunction is considered a pathogenic linker in the development of non-alcoholic steatohepatitis (NASH). Inappropriate mitochondrial protein-quality control, possibly induced by insufficiency of the mitochondrial matrix caseinolytic...
9.
Lee N, Heo Y, Choi S, Jeon J, Han S, Kim D, et al.
Biochem Biophys Res Commun
. 2021 Dec;
588:154-160.
PMID: 34971904
Non-alcoholic fatty liver disease (NAFLD) includes a broad spectrum of liver diseases characterized by steatosis, inflammation, and fibrosis. This study aimed to investigate the potential of dipeptidyl peptidase-4 inhibitors and...
10.
Lee J, Kang Y, Kim H, Kim D, Lee K, Han S
Int J Mol Sci
. 2021 Sep;
22(18).
PMID: 34576117
We aimed to investigate the effect of acute glucose shift on the activation of the NLRP3 inflammasome, IL-1β secretion, and underlying signaling pathways in THP-1 cells. THP-1 cells were divided...